T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZINC
1301
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $11.8M | ﹤0.01% |
1,009,030
+1,200
| +0.1% | +$15.7K |
|
|
POLY
1302
DELISTED
Plantronics, Inc.
POLY
| $11.7M | ﹤0.01% |
208,450
+7,500
| +4% | +$418K |
|
1303
Ziff Davis
ZD
$1.9B
| $11.7M | ﹤0.01% |
197,915
+11,845
| +6% | +$701K |
|
1304
Pinnacle West Capital
PNW
$12.3B
| $11.6M | ﹤0.01% |
204,280
+6,500
| +3% | +$392K |
|
|
KS
1305
DELISTED
KapStone Paper and Pack Corp.
KS
| $11.6M | ﹤0.01% |
501,300
-1,079,940
| -68% | -$29.8M |
|
|
NFX
1306
DELISTED
Newfield Exploration
NFX
| $11.6M | ﹤0.01% |
320,840
-341,870
| -52% | -$12.7M |
|
1307
ICU Medical
ICUI
$4.57B
| $11.5M | ﹤0.01% |
120,100
+20,000
| +20% | +$1.87M |
|
|
CLCD
1308
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $11.3M | ﹤0.01% |
+1,273,590
| New | +$10.9M |
|
1309
Allot
ALLT
$380M
| $11.3M | ﹤0.01% |
1,575,770
+31,940
| +2% | +$260K |
|
|
BBNK
1310
DELISTED
BRIDGE CAPITAL HOLDINGS
BBNK
| $11.3M | ﹤0.01% |
380,190
+1,200
| +0.3% | +$33.6K |
|
|
CBK
1311
DELISTED
Christopher & Banks Corporation
CBK
| $11.3M | ﹤0.01% |
2,824,402
-95,835
| -3% | -$526K |
|
1312
Spectrum Brands
SPB
$2.07B
| $11.3M | ﹤0.01% |
110,700
+105,300
| +1,950% | +$9.9M |
|
1313
Insulet
PODD
$10.1B
| $11.2M | ﹤0.01% |
362,241
+8,700
| +2% | +$256K |
|
|
INXN
1314
DELISTED
Interxion Holding N.V.
INXN
| $11.1M | ﹤0.01% |
+400,600
| New | +$11.9M |
|
|
DYN
1315
DELISTED
Dynegy, Inc.
DYN
| $11.1M | ﹤0.01% |
377,809
+200
| +0.1% | +$6.5K |
|
|
JMP
1316
DELISTED
JMP Group LLC
JMP
| $11M | ﹤0.01% |
1,413,612
-14,300
| -1% | -$112K |
|
1317
WisdomTree
WT
$3.45B
| $10.9M | ﹤0.01% |
497,329
+455,129
| +1,079% | +$9.6M |
|
|
COHR
1318
DELISTED
Coherent Inc
COHR
| $10.8M | ﹤0.01% |
170,500
-7,200
| -4% | -$462K |
|
|
ANAC
1319
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $10.8M | ﹤0.01% |
139,700
+52,600
| +60% | +$3.45M |
|
|
SNI
1320
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $10.8M | ﹤0.01% |
165,070
-990
| -0.6% | -$67.5K |
|
|
ACOR
1321
DELISTED
Acorda Therapeutics
ACOR
| $10.8M | ﹤0.01% |
2,689
-33
| -1% | -$127K |
|
|
ZQK
1322
DELISTED
QUICKSILVER,INC.
ZQK
| $10.7M | ﹤0.01% |
16,090,790
-9,155,409
| -36% | -$12.5M |
|
|
AIV
1323
Aimco
AIV
$382M
| $10.6M | ﹤0.01% |
2,162,463
+206,227
| +11% | +$1.04M |
|
|
MASI
1324
DELISTED
Masimo
MASI
| $10.6M | ﹤0.01% |
274,530
+37,600
| +16% | +$1.35M |
|
1325
Ribbon Communications
RBBN
$372M
| $10.6M | ﹤0.01% |
1,530,978
-4,500
| -0.3% | -$35.3K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.